Bochnia

Poland

5 total trials

Filter these 5 trials by phase, condition, sponsor and more.

Open in Search →

A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects with Moderate-t … Ended recruitment

2024-512496-12-00 5 2025-04-01 Moderate to Severe Plaque Psoriasis
A study to investigate the efficacy and safety of subcutaneous lunsekimig (SAR443765) compared with placebo in adult participants with moder … Ended

2024-511549-20-00 4 2025-04-22 Dermatitis atopic
Evaluation of efficacy and safety of 0.1% mometasone furoate cutaneous emulsion compared to its active ingredient-free base and a comparator … Ended

2024-511583-82-00 5 2024-10-08 Plaque psoriasis
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 With a Randomized Withdrawal and Retreatment Period in Subject … Ended

2023-505842-24-00 5 2024-05-07 Moderate to Severe Plaque Psoriasis
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease Ended

2024-511553-22-00 5 2018-10-05 Moderately to Severely Active Crohn's Disease

Showing 1–5 of 5 trials